Clinical data supporting mechanism of action reinforce potential as a novel cancer treatmentBRISBANE, Calif., March 25, 2025 ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

The abstracts will be available on the AACR 2025 meeting website. The posters will be available online at Erasca.com/science/presentations following the presentations.

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH st ...

Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy ...

The National Comprehensive Cancer Network® (NCCN®) is sharing a webinar today that answers critical patient questions about ...

Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.

Following the meeting, the poster presentations will be available on Bicara's website at www.bicara.com.

Abstract accepted for late-breaking poster presentation – -- EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid ...

A test for abnormal fetal chromosomes can also detect maternal cancers—and physicians are struggling to incorporate that ...

A spaghetti dinner and bake sale to benefit Myndi and Scott Farling will be held from 3 to 6:30 p.m. Saturday, May 10 at the ...